The company takes the technical innovation of molecular detection methods as the core driving force, and focuses on the R＆D and industrialization of molecular diagnostic products aiming at ...
As the SARS-CoV-2 virus quickly spread around the globe ... "We can actually unpack it and have it ready to test in about five minutes." Sponsor Message His team – lead by his postdoctoral ...
The pandemic hit Manchester much like it did elsewhere in the country, and across the world - suddenly and shockingly, upending everyday life in ways never thought possible.
CoV-2 nucleocapsid antibodies to detect exposure to SARS-CoV-2: results from a prospective cohort study on COVID-19 ...
StockNews.com initiated coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research report sent to investors on Monday. The firm issued a sell rating on the medical research company’s stock.
Gene Bio Medical (GBM), a leading Canadian biotechnology company specializing in molecular diagnostics, has signed a ...
Clinical Trials Arena on MSN6d
INOVIO’s Covid-19 dMAb maintains in-vivo detection in 100% participantsResults saw all 24 healthy volunteers who made it to the 72-week mark still had effective levels of dMAB in their systems.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback